Charlottesville, VA2 Active Studies

Valvular Heart Disease Clinical Trials in Charlottesville, VA

Find 2 actively recruiting valvular heart disease clinical trials in Charlottesville, VA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
700
Enrolling

Recruiting Valvular Heart Disease Studies in Charlottesville

About Valvular Heart Disease Clinical Trials in Charlottesville

Valvular heart disease occurs when one or more heart valves do not function properly, disrupting blood flow through the heart. Common types include aortic stenosis and mitral regurgitation. Treatment ranges from monitoring to surgical valve repair or replacement.

There are currently 2 valvular heart disease clinical trials recruiting participants in Charlottesville, VA. These studies are seeking a combined 700 participants. Research is being sponsored by EnCompass Technologies, Inc., University of Virginia. Clinical trial participation is free and participants receive study-related medical care at no cost.

Valvular Heart Disease Clinical Trials in Charlottesville — FAQ

Are there valvular heart disease clinical trials in Charlottesville?

Yes, there are 2 valvular heart disease clinical trials currently recruiting in Charlottesville, VA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charlottesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charlottesville research site will contact you about next steps.

Are clinical trials in Charlottesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charlottesville studies also compensate for your time and travel.

What valvular heart disease treatments are being tested?

The 2 active trials in Charlottesville are testing new therapies including novel drugs, biologics, and treatment approaches for valvular heart disease.

Data updated July 13, 2026 from ClinicalTrials.gov